29 Marzo 2019

New EudraVigilance system improves reporting of side effects and detection of safety signals

March 27, 2019 – The new and improved EudraVigilance, the European system for managing and analysing information on suspected adverse reactions to medicines that are authorised or being studied in clinical trials in the EU, received more than 2 million reports of suspected side effects in 2018. This is an increase of 37% compared to 2017 which largely reflects that from November 2017 the national competent authorities and the marketing authorisation holders were … (leggi tutto)